GGrantIndex
Sort

51,593 grants matching hepatitis

NOX family NADPH oxidases: roles in innate immunity and inflammatory disease

$619,098
Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Molecular pathogenesis of blastomycosis

$619,068
Bruce Steven Klein · University Of Wisconsin-Madison · R37 · FY2024 · AI

Continuum of Care for Drug-Involved Offenders

$619,034
Peter D. Friedmann · Rhode Island Hospital · U01 · FY2012 · DA

Early-Stage Chronic Kidney Disease in HIV-infected Individuals

$618,943
Gregory M Lucas · Johns Hopkins University · R01 · FY2016 · DA

Biomarkers to Identify Individuals at RIsk for Progression of S. Japonicum Associated Hepatic Fibrosis with Point of Care Test Development

$618,935
Jennifer F Friedman · Rhode Island Hospital · U01 · FY2023 · AI

Optimization of fibroblast-selective inhibitors of YAP/TAZ as novel therapeutics for Pulmonary Fibrosis

$618,908
Susanne Heynen-Genel · Sanford Burnham Prebys Medical Discovery Institute · R61 · FY2023 · HL

Probing the antibody response to HCV to facilitate rational immunogen design

$618,839
Dennis R. Burton · Scripps Research Institute, The · R01 · FY2011 · AI

HBV Prevention for Homeless at Risk for HBV/HCV/HIV

$618,727
Adeline M Nyamathi · University Of California Los Angeles · R01 · FY2011 · DA

Sample Processing and Analytical Methods Development for New Anticancer Agents

$618,723
William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2012 · CA

NATIONAL HIV BEHAVIORAL SURVEILLANCE IN THE DISTRICT OF COLUMBIA

$618,621
Tiffany A West · Dc Department Of Health · U1B · FY2011 · PS

Non Alcoholic Steatohepatitis Clinical Research Network

$618,611
Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2022 · DK

Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis

$618,592
Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA

Administrative Core

$618,585
Massachusetts General Hospital · P30 · FY2007 · DK

Biochemical and Genetic Markers of Type 2 Diabetes Risk

$618,558
Frank B Hu · Brigham And Women'S Hospital · R01 · FY2011 · DK

GENERATION/EMERGENCE OF VARIANT IN HEPADNAVIRUS INFECTON

$618,521
University Of New Mexico · R01 · FY2000 · CA

Non-canonical mechanisms of translation of viral mRNAs

$618,497
Christopher Ulrich Tristram Hellen · Suny Downstate Medical Center · R01 · FY2018 · AI

Non-canonical mechanisms of translation of viral mRNAs

$618,497
Christopher Ulrich Tristram Hellen · Suny Downstate Medical Center · R01 · FY2019 · AI

Non-canonical mechanisms of translation of viral mRNAs

$618,497
Christopher Ulrich Tristram Hellen · Suny Downstate Medical Center · R01 · FY2017 · AI

Non-canonical mechanisms of translation of viral mRNAs

$618,497
Christopher Ulrich Tristram Hellen · Suny Downstate Medical Center · R01 · FY2020 · AI

Transforming Clinical and Translational Research and Education at Rockefeller

$618,491
Barry Coller · Rockefeller University · UL1 · FY2009 · RR

Mechanisms of Statin-Induced DM in JUPITER (Rosuvasatin for CVD Prevention)

$618,396
Aruna Das Pradhan · Brigham And Women'S Hospital · R01 · FY2010 · HL

Nucleic Acid Footprinting and development of small molecule antagonists

$618,327
Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Interventions to Increase HBV Vaccination in STD Clinics

$618,319
Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2004 · AI

Anti-HIV Microbicidal Peptides

$618,237
Philippe Andre Gallay · Scripps Research Institute, The · R21 · FY2010 · AI

Iron Deficiency and Anemia in HIV and HCV Infected Women

$618,203
Johns Hopkins University · R01 · FY2001 · DA